Navigation Links
NanoBio to Announce Key Clinical and Preclinical Data on Its Topical Anti-infective Lotions at AAD 2009

ANN ARBOR, Mich., March 2 /PRNewswire/ -- NanoBio Corp. announced today that it will present compelling new data highlighting key clinical and preclinical milestones in the development of its novel topical treatments for herpes labialis, onychomycosis and tinea capitis. The new data will be delivered in five presentations during the 2009 meeting of the American Academy of Dermatology in San Francisco, March 6-9, 2009.

In addition to the oral poster presentations listed below, the presentations will be available electronically at the kiosks provided by the AAD during the conference. NanoBio will also sponsor corporate booth # 5284, where information on the company's development programs for acne, herpes and antifungal products will be available.

Oral Poster Presentations

Saturday, March 7, 2009 -- Center 3

Poster # P2411, 10:20 a.m. -- Antifungal Activity and Mechanism of Action of NB-002, a Novel Topical Antifungal, Against the Major Pathogens of Onychomycosis

Poster # P2423, 12:20 p.m. -- Antifungal Activity of NB-002, a Topical Nanoemulsion, Against Rare Fungal Pathogens of Onychomycosis

Poster # P2505, 2:00 p.m. -- Investigator Assessed Time to Healing in a Randomized, Double-Blind, Vehicle-Controlled Trial of a Novel Antiviral Nanoemulsion (NB-001) for Recurrent Herpes Labialis

Poster # P2517, 4:00 p.m. -- Safety, Tolerability and Pharmacokinetics of Topical NB-001 (0.1%, 0.3% and 0.5%) for the Treatment of Recurrent Herpes Labialis

Sunday, March 8, 2009 - Center 1

Poster # P2114, 10:40 a.m. -- A Randomized, Double-Blind, Vehicle-Controlled Trial of Novel Topical Antifungal Nanoemulsion (NB-002) in Subjects With Distal Subungual Onychomycosis

About NanoBio

NanoBio(R) Corp. is a privately held biopharmaceutical company focused on developing and commercializing dermatological products, anti-infective treatments and intranasal vaccines derived from its patented NanoStat(TM) technology platform. The company's lead product candidates are treatments for herpes labialis (cold sores), onychomycosis (nail fungus), acne, cystic fibrosis and a broad platform of intranasal vaccines. The company's headquarters and laboratory facilities are located in Ann Arbor, Michigan.

SOURCE NanoBio Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nanobiotix and BiotechCorp Announce Initial Focus of Their Collaboration: P-O-C Diagnostics and Drug Delivery Systems for Tropical Diseases, Such as Malaria
2. UCLA, Tokyo University nanobiotechnology symposium at UCLA to highlight advances in nanomedicine
3. NanoBio Wins 2007 Michigan Innovation Award
4. MedThink Communications Retained by NanoBio Corporation
5. MHA Announces: Launch of New Website
6. National Instruments Announces New Suite of Prototyping Hardware to Lower Development Time and Costs
7. Lilly Announces Leadership Changes
8. Availity Announces Support of Project SwipeIT
9. The Vitality Group Announces Expansion to Board of Directors
10. Endo Pharmaceuticals Announces Extension of its Tender Offer for Shares of Indevus Pharmaceuticals
11. Boston Scientific Announces Election Of John Sununu To Its Board Of Directors
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director ... about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for ... and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... On November ... United States District Court of Connecticut on behalf of a home health care worker ... all current or former home health care workers employed by Humana, Inc., Humana at ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an ... is being more and more widely heralded as a breakthrough for performing hernia repairs. ... has over traditional laparoscopic surgery is that it can greatly reduce the pain that ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dental professionals who would like to become ... invited to attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will ... , As the co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio ...
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon Health Partners, the ... Wimbledon Athletics Facebook page to educate the public, parents and school ... About 2,000 people under the age of 25 die from sudden cardiac arrest ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ( ... Cardiac Pacemaker Market Outlook to 2019 - Rise in Cardiac ... " report to their offering. ... Boston scientific and others. --> ... Medtronic, Biotronik, Boston scientific and others. ...
(Date:11/26/2015)... Research and Markets ( ) ... Future Horizons and Growth Strategies in the Japanese ... Segment Forecasts, Competitive Intelligence, Emerging Opportunities" report ... --> This new 247-page report ... drug monitoring market, including emerging tests, technologies, instrumentation, ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology: